Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.

Roman M, Hubbard RA, Sebuodegard S, Miglioretti DL, Castells X, Hofvind S.

Cancer. 2013 Nov 15;119(22):3952-8. doi: 10.1002/cncr.28320.

2.
3.

The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.

Roman M, Skaane P, Hofvind S.

Eur J Radiol. 2014 Sep;83(9):1639-44. doi: 10.1016/j.ejrad.2014.05.038.

PMID:
24972452
4.

Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL.

Ann Intern Med. 2011 Oct 18;155(8):481-92. doi: 10.7326/0003-4819-155-8-201110180-00004. Erratum in: Ann Intern Med. 2014 May 6;160(9):658.

5.

Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.

O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL.

Cancer. 2013 Nov 15;119(22):3959-67. doi: 10.1002/cncr.28310.

6.

Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.

Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES; Breast Cancer Surveillance Consortium..

JAMA Intern Med. 2013 May 13;173(9):807-16. doi: 10.1001/jamainternmed.2013.307.

7.

Breast cancer detection risk in screening mammography after a false-positive result.

Castells X, Román M, Romero A, Blanch J, Zubizarreta R, Ascunce N, Salas D, Burón A, Sala M; Cumulative False Positive Risk Group..

Cancer Epidemiol. 2013 Feb;37(1):85-90. doi: 10.1016/j.canep.2012.10.004.

8.

Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.

Otten JD, Fracheboud J, den Heeten GJ, Otto SJ, Holland R, de Koning HJ, Broeders MJ, Verbeek AL.

Ann Oncol. 2013 Oct;24(10):2501-6. doi: 10.1093/annonc/mdt227.

PMID:
23788759
9.

Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K; Breast Cancer Surveillance Consortium..

J Natl Cancer Inst. 2013 Mar 6;105(5):334-41. doi: 10.1093/jnci/djs645.

10.

Benefits and Harms of Breast Cancer Screening: A Systematic Review.

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD.

JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. Review. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

11.

Ten-year risk of false positive screening mammograms and clinical breast examinations.

Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW.

N Engl J Med. 1998 Apr 16;338(16):1089-96.

12.

Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening.

Román R, Sala M, Salas D, Ascunce N, Zubizarreta R, Castells X; Cumulative False Positive Risk Group..

Ann Oncol. 2012 Jan;23(1):104-11. doi: 10.1093/annonc/mdr032.

13.

Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.

Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL; Breast Cancer Surveillance Consortium..

J Gen Intern Med. 2013 Nov;28(11):1454-62. doi: 10.1007/s11606-013-2507-0.

14.

Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.

Winch CJ, Sherman KA, Boyages J.

Breast Cancer Res Treat. 2015 Jan;149(1):211-21. doi: 10.1007/s10549-014-3226-x.

PMID:
25476499
15.

Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.

Domingo L, Romero A, Blanch J, Salas D, Sánchez M, Rodríguez-Arana A, Ferrer J, Ibáñez J, Vega A, Laso MS, Castells X, Sala M.

Cancer Epidemiol. 2013 Oct;37(5):660-5. doi: 10.1016/j.canep.2013.07.006.

PMID:
23962702
16.

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Törnberg S; EUNICE Project and Euroscreen Working Groups., Van Hal G, Martens P, Májek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Péntek Z, Budai A, Mádai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sánchez-Contador Escudero C, Zubizarreta Alberti R, Fernández Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibáñez Cabanell J, Wiege M, Ohlsson G, Törnberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E.

J Med Screen. 2012;19 Suppl 1:57-66. Review.

PMID:
22972811
17.
18.

The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.

Hauge IH, Pedersen K, Olerud HM, Hole EO, Hofvind S.

Acta Radiol. 2014 Dec;55(10):1174-9. doi: 10.1177/0284185113514051.

PMID:
24311702
19.

Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.

Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti D.

Ann Intern Med. 2016 Feb 16;164(4):226-35. doi: 10.7326/M15-0971.

PMID:
26756902
20.
Items per page

Supplemental Content

Support Center